|
1
|
Buckwalter JA: Aging and degeneration of
the human intervertebral disc. Spine (Phila Pa 1976). 20:1307–1314.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Costi JJ, Stokes IA, Gardner-Morse MG and
Iatridis JC: Frequency-dependent behavior of the intervertebral
disc in response to each of six degree of freedom dynamic loading:
Solid phase and fluid phase contributions. Spine (Phila Pa 1976).
33:1731–1738. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kalichman L and Hunter DJ: The genetics of
intervertebral disc degeneration. Familial predisposition and
heritability estimation. Joint Bone Spine. 75:383–387. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Friedman BW, O'Mahony S, Mulvey L, Davitt
M, Choi H, Xia S, Esses D, Bijur PE and Gallagher EJ: One-week and
3-month outcomes following an emergency department visit for
undifferentiated musculoskeletal low back pain. Ann Emerg Med.
59:128–133. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kepler CK, Ponnappan RK, Tannoury CA,
Risbud MV and Anderson DG: The molecular basis of intervertebral
disc degeneration. Spine J. 13:318–330. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gopal D, Ho AL, Shah A and Chi JH:
Molecular basis of intervertebral disc degeneration. Adv Exp Med
Biol. 760:114–133. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen Y, Chen K, Li M, Li C, Ma H, Bai YS,
Zhu XD and Fu Q: Genes associated with disc degeneration identified
using microarray gene expression profiling and bioinformatics
analysis. Genet Mol Res. 12:1431–1439. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tsai TT, Lai PL, Liao JC, Fu TS, Niu CC,
Chen LH, Lee MS, Chen WJ, Fang HC, Ho NY and Pang JH: Increased
periostin gene expression in degenerative intervertebral disc
cells. Spine J. 13:289–298. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He J, Xue R, Li S, Lv J, Zhang Y, Fan L,
Teng Y and Wei H: Identification of the potential molecular targets
for human intervertebral disc degeneration based on bioinformatic
methods. Int J Mol Med. 36:1593–1600. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Choi YS: Pathophysiology of degenerative
disc disease. Asian Spine J. 3:39–44. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kazezian Z, Gawri R, Haglund L, Ouellet J,
Mwale F, Tarrant F, O'Gaora P, Pandit A, Alini M and Grad S: Gene
expression profiling identifies interferon signalling molecules and
IGFBP3 in human degenerative annulus fibrosus. Sci Rep.
5:156622015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Troyanskaya O, Cantor M, Sherlock G, Brown
P, Hastie T, Tibshirani R, Botstein D and Altman RB: Missing value
estimation methods for DNA microarrays. Bioinformatics. 17:520–525.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fujita A, Sato JR, Lde O Rodrigues,
Ferreira CE and Sogayar MC: Evaluating different methods of
microarray data normalization. BMC Bioinformatics. 7:4692006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:Article 3, 2004. doi:
10.2202/1544-6115.1027. PubMed/NCBI
|
|
16
|
da W Huang, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
|
|
17
|
Kanehisa M and Goto S: KEGG: Kyoto
Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie C, Mao X, Huang J, Ding Y, Wu J, Dong
S, Kong L, Gao G, Li CY and Wei L: KOBAS 2.0: A web server for
annotation and identification of enriched pathways and diseases.
Nucleic Acids Res. 39:W316–W322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Duncan D, Shi Z and Zhang B:
WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): Update 2013.
Nucleic Acids Res. 41:W77–W83. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang B, Kirov S and Snoddy J: WebGestalt:
An integrated system for exploring gene sets in various biological
contexts. Nucleic Acids Res. 33:W741–W748. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hynes RO: The extracellular matrix: Not
just pretty fibrils. Science. 326:1216–1219. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Frantz C, Stewart KM and Weaver VM: The
extracellular matrix at a glance. J Cell Sci. 123:4195–4200. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bornstein P: Matricellular proteins: An
overview. J Cell Commun Signal. 3:163–165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mitra SK, Hanson DA and Schlaepfer DD:
Focal adhesion kinase: In command and control of cell motility. Nat
Rev Mol Cell Biol. 6:56–68. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiang J, Bian C, Wang H, Huang S and Wu D:
miR-203 down-regulates Rap1A and suppresses cell proliferation,
adhesion and invasion in prostate cancer. J Exp Clin Cancer Res.
34:82015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mott HR and Owen D: Structures of Ras
superfamily effector complexes: What have we learnt in two decades?
Crit Rev Biochem Mol Biol. 50:85–133. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sadler AJ and Williams BR:
Interferon-inducible antiviral effectors. Nat Rev Immunol.
8:559–568. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brierley MM and Fish EN: Review:
IFN-alpha/beta receptor interactions to biologic outcomes:
Understanding the circuitry. J Interferon Cytokine Res. 22:835–845.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Foser S, Redwanz I, Ebeling M, Heizmann CW
and Certa U: Interferon-alpha and transforming growth factor-beta
co-induce growth inhibition of human tumor cells. Cell Mol Life
Sci. 63:2387–2396. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kiepe D, Ulinski T, Powell DR, Durham SK,
Mehls O and Tönshoff B: Differential effects of insulin-like growth
factor binding proteins-1, −2, −3 and −6 on cultured growth plate
chondrocytes. Kidney Int. 62:1591–1600. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pritchard CC, Cheng HH and Tewari M:
MicroRNA profiling: Approaches and considerations. Nat Rev Genet.
13:358–369. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu YQ, Zhang ZH, Zheng YF and Feng SQ:
Dysregulated miR-133a mediates loss of type II collagen by directly
targeting matrix metalloproteinase 9 (MMP9) in human intervertebral
disc degeneration. Spine (Phila Pa 1976). 41:E717–E724. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ji ML, Zhang XJ, Shi PL, Lu J, Wang SZ,
Chang Q, Chen H and Wang C: Downregulation of microRNA-193a-3p is
involved in invertebral disc degeneration by targeting MMP14. J Mol
Med (Berl). 94:457–468. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wallace E, Morrell NW, Yang XD, Long L,
Stevens H, Nilsen M, Loughlin L, Mair KM, Baker AH and MacLean MR:
A sex-specific microRNA-96/5-hydroxytryptamine 1B axis influences
development of pulmonary hypertension. Am J Respir Crit Care Med.
191:1432–1442. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu L, Pu X, Wang Q, Cao J, Xu F, Xu LI and
Li K: miR-96 induces cisplatin chemoresistance in non-small cell
lung cancer cells by downregulating SAMD9. Oncol Lett. 11:945–952.
2016.PubMed/NCBI
|
|
36
|
Yu S, Lu Z, Liu C, Meng Y, Ma Y, Zhao W,
Liu J, Yu J and Chen J: miRNA-96 suppresses KRAS and functions as a
tumor suppressor gene in pancreatic cancer. Cancer Res.
70:6015–6025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bian DL, Wang XM, Huang K, Zhai QX, Yu GB
and Wu CH: Expression and regulatory effects of microRNA-182 in
osteosarcoma cells: A pilot study. Oncol Lett. 11:3040–3048.
2016.PubMed/NCBI
|
|
38
|
Kundu ST, Byers LA, Peng DH, Roybal JD,
Diao L, Wang J, Tong P, Creighton CJ and Gibbons DL: The miR-200
family and the miR-183~96~182 cluster target Foxf2 to inhibit
invasion and metastasis in lung cancers. Oncogene. 35:173–186.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Y, Wang X, Wang Z, Tang H, Fan H and
Guo Q: miR-182 promotes cell growth and invasion by targeting
forkhead box F2 transcription factor in colorectal cancer. Oncol
Rep. 33:2592–2598. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kong PZ, Yang F, Li L, Li XQ and Feng YM:
Decreased FOXF2 mRNA expression indicates early-onset metastasis
and poor prognosis for breast cancer patients with histological
grade II tumor. PLoS One. 8:e615912013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Van der Heul-Nieuwenhuijsen L, Dits N, Van
Ijcken W, de Lange D and Jenster G: The FOXF2 pathway in the human
prostate stroma. Prostate. 69:1538–1547. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ormestad M, Astorga J, Landgren H, Wang T,
Johansson BR, Miura N and Carlsson P: Foxf1 and Foxf2 control
murine gut development by limiting mesenchymal Wnt signaling and
promoting extracellular matrix production. Development.
133:833–843. 2006. View Article : Google Scholar : PubMed/NCBI
|
